ArticleSchmerz (Berlin, Germany)2012
[German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies].
Article in Schmerz (Berlin, Germany), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 4 syntheses or guidelines pooled it, 32 citations in OpenAlex.
- Mirtazapine for fibromyalgia in adults.The Cochrane database of systematic reviews · 2018Pooled it
- [Physiotherapy, occupational therapy and physical therapy in fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].Schmerz (Berlin, Germany) · 2017Pooled it
- [Drug therapy of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].Schmerz (Berlin, Germany) · 2017Pooled it
- Selective serotonin reuptake inhibitors for fibromyalgia syndrome.The Cochrane database of systematic reviews · 2015Pooled it
- [Etiological factors in chronic widespread pain and/or fibromyalgia syndrome: subjective perspectives of patients, general practitioners and psychotherapists : A pilot study].Schmerz (Berlin, Germany) · 2025Article
- A Prospective Observational Study of a 2-Week Integrative Inpatient Therapy on Patients with Fibromyalgia Syndrome.Biomedicines · 2025Article
- ["But you've got to do something yourself as well" : Coping with fibromyalgia syndrome (FMS): perspectives of those affected and those treating them in Saarland].Schmerz (Berlin, Germany) · 2021Article
- Article
- [Healthcare services research on pain in Germany. A survey].Schmerz (Berlin, Germany) · 2015Article
- [Psychotherapeutic procedures for fibromyalgia syndrome].Zeitschrift fur Rheumatologie · 2015Review
- A Systematic Overview of Reviews for Complementary and Alternative Therapies in the Treatment of the Fibromyalgia Syndrome.Evidence-based complementary and alternative medicine : eCAM · 2015Review
- Complementary and alternative medicine for the treatment of fibromyalgia.Evidence-based complementary and alternative medicine : eCAM · 2014Article
- [Are members of fibromyalgia syndrome self-help groups "different"? Demographic and clinical characteristics of members and non-members of fibromyalgia syndrome self-help groups].Zeitschrift fur Rheumatologie · 2013Article
- [Prevalence of chronic pain in Germany. A representative survey of the general population].Schmerz (Berlin, Germany) · 2013Article
- A systematic review and meta-analysis of qigong for the fibromyalgia syndrome.Evidence-based complementary and alternative medicine : eCAM · 2013Review
- [Benefits and disadvantages of therapy for fibromyalgia syndrome: new insights and decision aids from consumer reports?].Schmerz (Berlin, Germany) · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 8 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConsumer reports provide information on benefits and harms in routine clinical care. We report the first fibromyalgia syndrome (FMS) consumer reports in Europe. MATERIAL AND
methodsThe study was carried out from November 2010 to April 2011. The benefits and harms of pharmacological and non-pharmacological therapies experienced by the patient were assessed in an 11-point Likert scale (0=no, 10=very high benefit or harm) by a questionnaire. The questionnaire was distributed by the German League against Rheumatism and the German Fibromyalgia Association to their members and to all consecutive FMS patients of nine clinical centers of different levels of care.
resultsA total of 1,661 questionnaires (95% women, mean age 54 years) were analyzed. Self-management strategies (distraction, resting, aerobic exercise), physical therapies (warm and pool therapies), psychological therapies (education, psychotherapy), and inpatient multicomponent therapies were judged to be more efficacious and less harmful than all types of pharmacological therapies.
conclusionThe German fibromyalgia consumer reports highlight the importance of non-pharmcological therapies in the long-term management of FMS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.